Effect of Aniseed in treatment of gastrointestinal symptoms in Coronavirus disease

Phase 3

• Conditions: COVID-19 infection.; Covid-19, confirmed cases, positive test result; U07.1

• Registration Number: IRCT20120506009651N3
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 225

Inclusion Criteria

Patients from 18 years old to 70 years old with a diagnosis of Coronavirus based on clinical and laboratory symptoms; hospitalization, home quarantine and outpatients
Diarrhea, anorexia, nausea or vomiting and abdominal pain within 24-48 hr

Exclusion Criteria

Pregnant or nursing females
Organic disorders with survival time of less than 3 days
Significant allergic reactions to the herbal drug

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Diarrhea. Timepoint: Before and after intervention. Method of measurement: Visual analogue scale (VAS) questionnaire which graded from zero (no sign) to 10 (severe sign).;Anorexia. Timepoint: Before and after intervention. Method of measurement: Visual analogue scale (VAS) questionnaire which graded from zero (no sign) to 10 (severe sign).;Abdominal pain. Timepoint: Before and after intervention. Method of measurement: Visual analogue scale (VAS) questionnaire which graded from zero (no sign) to 10 (severe sign).

Secondary Outcome Measures

Name	Time	Method
Gastrointestinal disorders. Timepoint: End of Treatment (2 weeks after starting intervention). Method of measurement: Visual analogue scale (VAS) questionnaire.